Results 21 to 30 of about 40,571 (305)
Rhino-orbital Mucormycosis in a COVID-19 Patient: The First Case in Malaysia
Proceedings of Singapore Healthcare, 2022 Mucormycosis is an aggressive and potentially fatal fungal infection caused by fungi of the order Mucorales. There has been an increase in the number of cases of rhino-orbital mucormycosis in people with COVID-19, particularly in India.
Chee Yik Chang +3 more
doaj +1 more source
P284 A rare case of post covid bilateral renal mucormycosis
Medical Mycology, 2022 Poster session 2, September 22, 2022, 12:30 PM - 1:30 PM Objective The most commonly reported sites of COVID-associated invasive mucormycosis till now have been rhino-cerebral-orbital followed by pulmonary.
Manoj Shevkani
semanticscholar +1 more source
Anais Brasileiros de Dermatologia, 2017 Cutaneous mucormycosis is an emerging fungal infection caused by opportunistic fungi of the phylum Glomeromycota. It is frequent in poorly controlled diabetic patients and individuals with immunosuppression. It is usually acquired by direct inoculation through trauma.
Castrejón Pérez, Ana Daniela +4 more
openaire +6 more sources
Mucormycosis in COVID-19 patients: A tertiary care experience
Acta Medica International, 2022 Introduction: Zygomycetes consisting of Mucorales order is a group of fungal infections. These species cause life threatening opportunistic fungal infections mucormycosis. This infection is highly prevalent in immunocompromised.
Sarandeep Singh Puri +4 more
doaj +1 more source
Mucormycosis following COVID19: clinical case and literature review [PDF]
Клиническая микробиология и антимикробная химиотерапия, 2021 Mucormycosis is one of the most aggressive invasive mycoses. The mortality rate of patients with mucormycosis, depending on clinical form and background disease, varies from 30% to 100%.
Khostelidi S.N. +7 more
doaj +1 more source
What Is New in Pulmonary Mucormycosis?
Journal of Fungi, 2023 Mucormycosis is a rare but life-threatening fungal infection due to molds of the order Mucorales. The incidence has been increasing over recent decades.
F. Danion +9 more
semanticscholar +1 more source
Journal of Fungi, 2018 Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in addition to amphotericin B products, to our armamentarium against mucormycosis, many uncertainties remain for the management of this uncommon opportunistic infection, as there are no data from prospective randomized clinical trials to guide therapy.
Nikolaos V. Sipsas +3 more
openaire +4 more sources
Autopsy Case Reports, 2023 Mucormycosis is a life-threatening fungal infection caused by mucormycetes, fungi of the Mucorales order.1 Rhino-orbital-cerebral involvement is the most common form of invasive mucormycosis. However, gastrointestinal (GI) mucormycosis cases have increased in the last two to three decades.2 Involvement of the GI tract in invasive mucormycosis is seen ...
Sourav Bhowmik +3 more
openaire +3 more sources
A Systematic Review of the Therapeutic Outcome of Mucormycosis
Open Forum Infectious Diseases, 2023 Background Mucormycosis is a potentially lethal mycosis. We reviewed peer-reviewed publications on mucormycosis to assess therapeutic outcomes. Methods A systematic literature search using the Ovid MEDLINE and EMBASE databases identified manuscripts ...
L. S. M. Sigera, D. W. Denning
semanticscholar +1 more source
Conflicting interests in the pathogen-host tug of war : fungal micronutrient scavenging versus mammalian nutritional immunity [PDF]
, 2014 Funding: The authors are supported by the European Research Council (STRIFE project funded on grant number ERC-2009-AdG-249793, http://erc.europa.eu). AJPB is also supported by the Wellcome Trust (grant numbers 080088, 097377, www.wellcome.ac.uk) and the
Ballou, Elizabeth R +3 more
core +7 more sources